Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
Pneumococcal Infections (Phase 3)
Trials (1 total)
Trial APIs (2 total)